Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
![conference-3](https://isop2024montreal.org/wp-content/uploads/2023/09/conference-3-1.png)
05 Days
115 Speakers
![Asset 11](https://isop2024montreal.org/wp-content/uploads/2023/09/Asset-11.png)
Pre-Conference Schedule
Pre-Conference
Tuesday
01
08:00 | 📍Hotel Omni Mont-Royal
PC I: Safety First, Introduction to Pharmacovigilance
![](https://isop2024montreal.org/wp-content/uploads/2024/01/Katarina-Ilic.jpg)
Katarina Ilic, Celldex Therapeutics, USA
Francesco Salvo, Université de Bordeaux
Ushma Mehta, Cape Town University
Charles Khouri, CHU Grenoble Tina Bostic, Novavax Natália Kalousová Kocánková, Primevigilance John Caminis, Icahn School of Medicine
Parallel Course |📍Hotel Omni Mont-Royal
PC II: RWE in Pharmacovigilance
![](https://isop2024montreal.org/wp-content/uploads/2024/01/Robert-Platt.jpg)
Robert Platt, McGill University
Gianluca Trifiro, Verona University
Luis Pinheiro, EMA
Marco Tuccori, University of Pisa
12:00
Lunch
13:00 |📍Hotel Omni Mont-Royal
PC III: Approaches for Signal Detection & Assessment from a National and a Global Perspective
![](https://isop2024montreal.org/wp-content/uploads/2024/05/Monica-Tarapues-UMC.jpg)
Mónica Tarapués, UMC
Salman Afsar, BMS Lisa Wolf, US FDA
Luis Pinheiro, EMA Alem Zekarias, UMC
Parallel Course |📍Hotel Omni Mont-Royal
PC IV: Regulatory Framework for Pharmacovigilance
![Monica Muñoz](https://isop2024montreal.org/wp-content/uploads/2024/01/Monica-Munoz-1.jpg)
Monica Munoz, US FDA
Kelly Robinson, Health Canada
Alison Cave, MHRA
Alex Dodoo, Ghana Standards Authority
17:00
End of day
Pre-Conference
Wednesday
02
08:00 | 📍Hotel Omni Mont-Royal
PC V: Practical Applications of Evidence-Based Medicine
![](https://isop2024montreal.org/wp-content/uploads/2024/01/Tarek-Hammad.jpg)
Tarek Hammad, Takeda
Salman Afsar, BMS
Parallel Course |📍Hotel Omni Mont-Royal
PC VI: Risk Management Plans (RMPs/REMS)
![](https://isop2024montreal.org/wp-content/uploads/2024/05/Jean-Christophe-Delumeau.jpg)
Jean-Christophe Delumeau, IPV
Maribel Salas, Bayer
Yola Moride, YolaRx Consultants, Rutgers University, USA
12:00
Lunch
13:00 |📍Hotel Omni Mont-Royal
PC VII: Benefit/Risk Assessment from different perspectives
![](https://isop2024montreal.org/wp-content/uploads/2024/05/Adel-Abou-Ali-Takeda.png)
Adel Abou Ali, Takeda
Sara Abdollahi, US FDA Ellen Janssen, J&J Uwe Niehaus, BPI
Tarek Hammad, Takeda
Parallel Course |📍Hotel Omni Mont-Royal
PC VIII: Practical Concepts in Risk Minimization Design and Evaluation
![Rania Mouchantaf](https://isop2024montreal.org/wp-content/uploads/2024/01/Rania-Mouchantaf.jpg)
Rania Mouchantaf, Health Canada
Jean-Christophe Delumeau, IPV
Yola Moride, YolaRx
Elaine Morrato, Loyola University
Priya Bahri, EMA
Thomas Stammschulte, SwissMedic